BIMI Holdings Inc. BIMI
At closeNov 3, 2026, 4:00 PM EST
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 1.40K
- Revenue (ttm)
- 12.63M
- Profit margin
- -83.20%
- EPS (ttm)
- -1.03
- Shares out
- 13.96M
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 26.25K
- Avg volume
- 472
- Open
- 0.0001
- Previous close
- 0.0001
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.0001 – 0.0005
- Beta
- 1.74
2Y -0.0199 (-99.50%)
Key statistics
- Enterprise value
- 5.78M
- PEG ratio
- 0.00
- Price / sales
- 0.03
- Price / book
- 0.02
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -48.80%
- Free cash flow
- -5.75M
- Total cash
- 994.13K
- Total debt
- 4.99M
- Return on equity
- -103.78%
- Short % of float
- 2.57%
- 50-day average
- 0.4896
- 200-day average
- 1.62
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 19, 2023 | Sep 1, 2023 | 0.00 | -0.49 | — | — |
| Nov 22, 2023 | Jun 1, 2023 | 0.00 | 0.26 | — | — |
| May 19, 2023 | Mar 1, 2023 | 0.00 | -0.24 | — | — |
| Nov 21, 2022 | Sep 1, 2022 | 0.00 | -1.60 | — | — |
| Aug 22, 2022 | Jun 1, 2022 | 0.00 | -1.80 | — | — |
| May 20, 2022 | Mar 1, 2022 | 0.00 | -2.70 | — | — |
About BIMI Holdings Inc.
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- usbimi.com
News
Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock Market 
Top 3 Health Care Stocks That Are Set To Fly This Quarter 
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session 
12 Health Care Stocks Moving In Wednesday's After-Market Session 
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session 
BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq 
12 Health Care Stocks Moving In Monday's Intraday Session 
BIMI Announces Results of 2023 Annual General Meeting of Stockholders 
BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results 
BIMI Announces Buyback of Warrants
Your note
Sign in to keep a note on BIMI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GANG LI | Chief Executive Officer | Sale | Apr 8, 2018 | 0 |
| LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 16, 2009 | 0 |
| LIHUA WANG | Chief Financial Officer | Sale | Apr 8, 2018 | 0 |
| OUDOM FNU | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 11, 2024 | 1,518,240 |
| SONG TIEWEI | Chief Executive Officer | Sale | Feb 27, 2024 | 337,117 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Natixis | 0.08% | 3,400 | 4.76K | Jun 29, 2023 |
| UBS Group AG | 0.06% | 2,484 | 3.48K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.01% | 357 | 353 | May 30, 2023 |